PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People\'s Republic of China.\', \'Graduate School of Peking Union Medical College, Beijing, People\'s Republic of China.\', \'Jiangsu Recbio Technology Co., Ltd., Taizhou, People\'s Republic of China.\', \'Beijing Advanced Innovation Center for Genomics (ICG) & Biomedical Pioneering Innovation Center (BIOPIC), Peking University; State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, People\'s Republic of China.\', \'Translational Medicine Institute, The First People\'s Hospital of Chenzhou, University of South China, Chenzhou, People\'s Republic of China.\', \'Department of Arboviral Vaccine, National Institutes for Food and Drug Control, Beijing, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/22221751.2021.2008775
?:doi
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 34818119
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all